Bioline Rx Ltd Adr has split its stock 2 times since its initial public offering (IPO). The first stock split occurred on July 15, 2019 with the ratio of 1-for-15, meaning that for 15 shares of BLRX owned pre-split, shareholders then owned 1 share. The most recent stock split took place on January 30, 2025 on a 1-for-40 basis.
These actions have increased BLRX stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that a stock split only change the number of shares and the price per share with no impact on Bioline Rx Ltd Adr's total market capitalization.
For more detailed information of Bioline Rx Ltd Adr's stock splits, view the table below:
The answer will depend on the decisions of the company's managers and market volatility. Bioline Rx Ltd Adr has not made an official announcement regarding whether it will enact a stock split or reverse stock split, but it has a history of doing so when BLRX stock prices become too high or too low for retail investors. Therefore, the ultimate decisions will certainly be made by Bioline Rx Ltd Adr's board of directors. Typically, no action is taken until its price per share reaches a specific threshold.
